Vogt-Koyanagi-Harada disease occurring during interferon-alpha and ribavirin therapy for chronic hepatitis C virus infection

International Ophthalmology

Volumn 30, Issue 5, 2010, Pages 611-613

  Al Muammar, Abdulrahman M ^a   Al Mudhaiyan, Tariq M ^a   Al Otaibi, Mohammed ^a   Abdo, Ayman ^a   Abu El Asrar, Ahmed M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Hepatitis C; Interferon; Vogt Koyanagi Harada Disease

Indexed keywords

ALPHA2B INTERFERON; ATROPINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISOLONE ACETATE; PREDNISONE; RIBAVIRIN;

ADULT; ARTICLE; CASE REPORT; CHRONIC DISEASE; CONJUNCTIVAL HYPEREMIA; DRUG WITHDRAWAL; HEPATITIS C; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; INTRAOCULAR PRESSURE; MALE; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; RETINA DETACHMENT; RETINA FLUORESCEIN ANGIOGRAPHY; SLIT LAMP; VISUAL ACUITY; VISUAL DISORDER; VOGT KOYANAGI SYNDROME;

ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FLUORESCEIN ANGIOGRAPHY; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; MALE; RIBAVIRIN; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 78649329386     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10792-010-9357-0     Document Type: Article

References (10)

1. RS Moorthy H Inomata NA Rao 1995 Vogt-Koyanagi-Harada syndrome Surv Ophthalmol 39 265 292 1:STN:280:DyaK2M3kt1ahtA%3D%3D 10.1016/S0039-6257(05) 80105-5 7725227
2. K Yamaki I Kondo H Nakamura, et al. 2000 Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in Lewis Rats Exp Eye Res 71 361 369 1:CAS:528:DC%2BD3cXmsFKlsrY%3D 10.1006/exer.2000.0893 10995557
3. T Kawano M Shigehira H Uto, et al. 1996 Retinal complications during interferon therapy for chronic hepatitis C Am J Gastroenterol 91 309 313 1:CAS:528:DyaK28XhvVWnt7g%3D 8607498
4. A Kasahara A Hiraide N Tomita, et al. 2004 Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C J Gastroenterol 39 1106 1109 10.1007/s00535-004-1452-4 15580406 (Pubitemid 39618796)
5. D Sène V Touitou B Bodaghi, et al. 2007 Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C World J Gastroenterol 13 3137 3140 17589934
6. DL Sylvestre AR Disston DP Bui 2003 Vogt-Koyanagi-Harada disease associated with interferon alpha-2b/ribavirin combination therapy J Viral Hepat 10 467 470 1:STN:280:DC%2BD3srlsVOlug%3D%3D 10.1046/j.1365-2893.2003.00456.x 14633182 (Pubitemid 37352590)
7. K Papastathopoulos E Bouzas G Naoum, et al. 2006 Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection J Infect 52 e59 e61 10.1016/j.jinf.2005.05.005 15951019 (Pubitemid 43137407)
8. V Touitou B Bodaghi N Cassoux, et al. 2005 Vogt-Koyanagi-Harada disease in patients with chronic hepatitis C Am J Ophthalmol 140 949 952 10.1016/j.ajo.2005.06.020 16310490 (Pubitemid 41727707)
9. V Touitou D Sene C Fardeau, et al. 2007 Interferon-alpha2a and Vogt-Koyanagi-Harada disease: a double-edged sword? Int Ophthalmol 27 211 215 10.1007/s10792-007-9040-2 17318324 (Pubitemid 46909263)
10. R Pellicano A Smedile S Peyre, et al. 2005 Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view Minerva Gastroenterol Dietol 51 55 61 1:STN:280: DC%2BD2M7isFeksQ%3D%3D 15756146